The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

12th CDDF SPRING CONFERENCE 2021

 

CURRENT AND FUTURE CHALLENGES OF

INNOVATIVE ONCOLOGY DRUG DEVELOPMENT 

Noordwijk aan Zee, Netherlands – 8-10 February 2021

 
CDDF SPRING CONFERENCE 2021

The Cancer Drug Development Forum (CDDF) Spring conference 2021 is a unique forum that convenes every year and gathers the leaders in the world of innovative cancer therapy development, including medical researchers, pharmaceutical industry representatives, regulatory authority representatives and patient advocacy groups. It is the successor of the former CDDF Alpine Conference and the 12th edition takes place from 8 to 10 February 2021, in the Netherlands. 

This multi-stakeholder, interactive meeting offers plenary lectures with moderated discussions, including case studies and networking opportunities. The programme focuses on the latest and future challenges of Innovative oncology drugs development with a special emphasis on patient access, cancer drug development in a global setting, advances in imaging and regulatory guidance on oncology drug development.

 

TARGET AUDIENCE

The target is a multidisciplinary audience of representatives from academia, EU and US regulatory bodies (EMA, FDA and national agencies), the pharmaceutical Industry, HTAs and patient advocates.

 

CONFERENCE SECRETARIAT

The Cancer Drug Development Forum 
c/o BLSI
Clos Chapelle-aux-Champs 30
1200 Brussels,
Belgium

Website: www.cddf.org
Phone: +32 2 880 62 70
Email: info@cddf.org

 

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70